Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · CMS publication 2026-06-30 View official record

Covered recipient · General Payments record

DANA MEREDITH CHASE

Allopathic & Osteopathic Physicians Obstetrics & Gynecology Gynecologic Oncology

NPI
1396888947
CMS profile
290086
Location
LOS ANGELES, CA

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

Saved items

Saved only in this browser. No account or alerts.

Filter and download payment records

General Payments · PY2023 · Entire year

$253,425.55

170 records · 0 disputed

Summary and payment records

  • CMS publication 2026-06-30
Read the payment records

“Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.”

— Centers for Medicare & Medicaid Services, Open Payments

A reported payment reflects a financial relationship a company disclosed. It does not indicate wrongdoing or a conflict of interest, and it says nothing about the quality of a provider's care.

These records are submitted to CMS and attested to by the reporting companies. CMS publishes them as reported; this site mirrors them without independent verification.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

How these totals are calculated
  • This total is the sum of the individual General Payments record amounts CMS published for the labeled program year(s); each record amount is used unmodified. The total itself is computed by this site. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Methodology & Data — sourcing, labeling, and limitations.

Provider summaries generated . CMS updates this data on an annual cycle, and corrections or successful disputes made at CMS may not yet appear here. The official CMS record is authoritative for the current state. View the official CMS record ↗

By nature of payment

PY2023 · entire year · sorted by reported total

By paying entity

PY2023 · entire year · sorted by reported total

Paying entityAmountRecords
GlaxoSmithKline, LLC. $101,079.33 48
AstraZeneca Pharmaceuticals LP $42,842.69 28
Eisai Inc. $39,110.94 29
Seagen Inc. $27,933.87 17
Genmab U.S., Inc. $18,747.39 10
Merck Sharp & Dohme LLC $10,681.99 8
ImmunoGen, Inc. $10,557.59 17
Karyopharm Therapeutics Inc. $1,874.15 10
Myriad Genetic Laboratories, Inc. $436.42 2
INTUITIVE SURGICAL, INC. $161.18 1

Page 2 of 4; records 51–100 of 170 matching records. This page contains 50 records (maximum 50), not the full filtered export. Use the CSV download for all matching records.

IndustryPayments · General Payments

DANA MEREDITH CHASE

NPI 1396888947 · CMS profile ID 290086

Allopathic & Osteopathic Physicians / Obstetrics & Gynecology / Gynecologic Oncology

LOS ANGELES, CA

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

General Payments, PY2023; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types

Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00

Page 2 of 4; records 51–100 of 170 matching records. This page contains 50 records (maximum 50), not the full filtered export.

Filtered page: https://industrypayments.org/provider/npi-1396888947?year=2023&recipient=provider&page=2#records-h

CMS source: https://openpaymentsdata.cms.gov/dataset/fb3a65aa-c901-4a38-a813-b04b00dfa2a9

Cite these filtered records

The citation includes this program year, filters, data edition, and page of results.

Plain
DANA MEREDITH CHASE, NPI 1396888947, CMS profile ID 290086. General Payments, PY2023; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 2 of 4; records 51–100 of 170 matching records. This page contains 50 records (maximum 50), not the full filtered export. IndustryPayments. https://industrypayments.org/provider/npi-1396888947?year=2023&recipient=provider&page=2#records-h. Source: https://openpaymentsdata.cms.gov/dataset/fb3a65aa-c901-4a38-a813-b04b00dfa2a9.
APA 7
IndustryPayments. (2026). DANA MEREDITH CHASE, NPI 1396888947, CMS profile ID 290086. General Payments, PY2023; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 2 of 4; records 51–100 of 170 matching records. This page contains 50 records (maximum 50), not the full filtered export. [Filtered data set page]. https://industrypayments.org/provider/npi-1396888947?year=2023&recipient=provider&page=2#records-h. Source: https://openpaymentsdata.cms.gov/dataset/fb3a65aa-c901-4a38-a813-b04b00dfa2a9.
Bluebook
DANA MEREDITH CHASE, NPI 1396888947, CMS profile ID 290086, IndustryPayments, General Payments, PY2023; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types (Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00). Page 2 of 4; records 51–100 of 170 matching records. This page contains 50 records (maximum 50), not the full filtered export. Source: https://openpaymentsdata.cms.gov/dataset/fb3a65aa-c901-4a38-a813-b04b00dfa2a9. https://industrypayments.org/provider/npi-1396888947?year=2023&recipient=provider&page=2#records-h.

Centers for Medicare & Medicaid Services, Open Payments

Citation formats are provided for reference; check the requirements of your publication.

Payment records · PY2023

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

General Payments · PY2023 · Physicians and non-physician practitioners · CMS publication 2026-06-30

170 matching records · $253,425.55 reported total · 0 disputed

Nature of payment: All payment types

Records imported here (UTC).

Link to these filtered records · CMS source dataset ↗

Download all 170 matching records (CSV)

CSV includes CMS record IDs, source and publication dates, the data edition, and a link to these filters. Formula-like text cells are prefixed with an apostrophe for spreadsheet safety.

Showing records 51–100 of 170.

Paying entityAmountDate Nature of paymentDispute statusPublication flagsPublished Record IDSource
GlaxoSmithKline, LLC. $1,213.0209/26/2023 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1002884697 CMS
GlaxoSmithKline, LLC. $2,800.0009/22/2023 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1002884553 CMS
GlaxoSmithKline, LLC. $5,600.0009/22/2023 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1002884675 CMS
ImmunoGen, Inc. $10.8109/20/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1017247267 CMS
ImmunoGen, Inc. $67.8809/20/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1017247315 CMS
Seagen Inc. $631.4009/20/2023 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 995811455 CMS
Seagen Inc. $264.3509/20/2023 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 995811463 CMS
Seagen Inc. $104.0909/20/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 995811469 CMS
Seagen Inc. $644.6309/20/2023 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 995811503 CMS
Seagen Inc. $9,520.0009/20/2023 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 995811509 CMS
Seagen Inc. $97.7809/20/2023 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 995811531 CMS
Seagen Inc. $35.5509/20/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 995811627 CMS
ImmunoGen, Inc. $29.5809/19/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1017247271 CMS
ImmunoGen, Inc. $49.3409/19/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1017247275 CMS
ImmunoGen, Inc. $1,095.2609/19/2023 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1017247307 CMS
ImmunoGen, Inc. $333.5709/19/2023 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1017247311 CMS
AstraZeneca Pharmaceuticals LP $5,500.0009/18/2023 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1011447287 CMS
AstraZeneca Pharmaceuticals LP $2,055.0009/14/2023 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1011316873 CMS
AstraZeneca Pharmaceuticals LP $914.6709/13/2023 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1011289585 CMS
AstraZeneca Pharmaceuticals LP $58.9909/13/2023 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1015808483 CMS
GlaxoSmithKline, LLC. $2,600.0009/12/2023 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1002884573 CMS
GlaxoSmithKline, LLC. $5,200.0009/12/2023 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1002884721 CMS
GlaxoSmithKline, LLC. $4,800.0009/08/2023 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1002884663 CMS
Seagen Inc. $119.4409/07/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 995811367 CMS
Seagen Inc. $4,080.0009/07/2023 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 995811389 CMS
Seagen Inc. $667.5209/07/2023 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 995811395 CMS
GlaxoSmithKline, LLC. $129.6709/05/2023 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1002882638 CMS
GlaxoSmithKline, LLC. $1,200.0008/18/2023 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1002882851 CMS
GlaxoSmithKline, LLC. $1,600.0008/18/2023 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1002884727 CMS
ImmunoGen, Inc. $47.3608/18/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1017247263 CMS
GlaxoSmithKline, LLC. $4,800.0008/15/2023 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1002884687 CMS
GlaxoSmithKline, LLC. $107.4008/15/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1002884709 CMS
GlaxoSmithKline, LLC. $5,600.0008/02/2023 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1002882861 CMS
GlaxoSmithKline, LLC. $865.0207/28/2023 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1002882759 CMS
GlaxoSmithKline, LLC. $124.9807/28/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1002884763 CMS
Eisai Inc. $1,560.0007/26/2023 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1023306311 CMS
GlaxoSmithKline, LLC. $4,800.0007/06/2023 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1002882781 CMS
GlaxoSmithKline, LLC. $1,688.9306/28/2023 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1002882717 CMS
GlaxoSmithKline, LLC. $118.8106/28/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1002882827 CMS
GlaxoSmithKline, LLC. $119.8406/27/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1002882695 CMS
GlaxoSmithKline, LLC. $1,344.8406/27/2023 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1002884629 CMS
AstraZeneca Pharmaceuticals LP $5,500.0006/20/2023 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1012115097 CMS
ImmunoGen, Inc. $4,259.0006/20/2023 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1017247283 CMS
ImmunoGen, Inc. $1,096.9706/20/2023 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1017247291 CMS
ImmunoGen, Inc. $124.9906/20/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1017247295 CMS
Genmab U.S., Inc. $233.7406/17/2023 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1051343647 CMS
Genmab U.S., Inc. $30.0206/16/2023 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1051343641 CMS
Genmab U.S., Inc. $6,800.0006/16/2023 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1051343643 CMS
GlaxoSmithKline, LLC. $4,800.0006/16/2023 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1002884607 CMS
INTUITIVE SURGICAL, INC. $161.1806/13/2023 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1156537678 CMS

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2019 $287,401.65 290
PY2020 $102,429.83 75
PY2021 $100,131.71 70
PY2022 $181,662.00 124
PY2023 $253,425.55 170
PY2024 $219,218.10 141
PY2025 $144,892.79 99

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-06-30
Program years on this page
2019, 2020, 2021, 2022, 2023, 2024, 2025
Source files and profile matching
Generated from
OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.

Research Payments

One row per program year and role, newest year first · amounts for the two roles are never added together

Program yearRoleAmountRecords
PY2025 Principal investigator $431,331.21 5
PY2024 Principal investigator $12,585.28 2
PY2023 Principal investigator $27,872.80 2
PY2022 Principal investigator $14,720.00 6
PY2021 Principal investigator $255,839.70 20
PY2020 Principal investigator $113,891.00 19
PY2019 Principal investigator $658,008.20 53

Research Payments are a separate CMS dataset, shown here separately and never added to General Payments. A research payment is often made to an institution, with this provider named as a principal investigator; each record states which role applies.

“If you are a physician who served as a principal investigator on a research study, you may see the payments associated with that research study listed under your name. This does not necessarily mean the payments are attributed to you. The dollar amount of the record corresponds to the total payment; the amounts are not attributed to each individual on the record.”

— Centers for Medicare & Medicaid Services, Open Payments Frequently Asked Questions, FAQ #12224

Research Payments records · PY2025

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

5 records in PY2025

Research Payments records (CSV)

RolePaying entityAmount DateRecipientStudy Dispute statusPublishedRecord ID
Principal investigator 1 Merck Sharp & Dohme LLC $132,344.96 12/31/2025 Covered Recipient Teaching Hospital
Ronald Reagan Ucla
A phase I/II trial of the integration of radiotherapy into chemotherapy with pembrolizumab/bevacizumab in newly diagnosed Stage IVB cervical cancer No dispute reported 06/30/2026 1232935537
Principal investigator 1 Merck Sharp & Dohme LLC $4,681.50 08/31/2025 Covered Recipient Teaching Hospital
Ronald Reagan Ucla
A Phase 3, Randomized, Active-controlled, Open-label, Multicenter Study to Compare the Efficacy and Safety of MK-2870 Monotherapy Versus Treatment of Physician s Choice in Participants With Endometrial Cancer Who Have Received Prior Platinum-based Chemoth No dispute reported 06/30/2026 1232923012
Principal investigator 1 Merck Sharp & Dohme LLC $249,734.75 08/27/2025 Covered Recipient Teaching Hospital
Ronald Reagan Ucla
A phase I/II trial of the integration of radiotherapy into chemotherapy with pembrolizumab/bevacizumab in newly diagnosed Stage IVB cervical cancer No dispute reported 06/30/2026 1232935535
Principal investigator 1 ABBVIE INC. $37,520.00 07/28/2025 Covered Recipient Teaching Hospital
RONALD REAGAN UCLA
A Study of Ocular Toxicity Evaluation and Mitigation During Treatment With Mirvetuximab Soravtansine in Participants With Recurrent Ovarian Cancer With High Folate Receptor-Alpha Expression No dispute reported 06/30/2026 1202420428
Principal investigator 1 ABBVIE INC. $7,050.00 07/28/2025 Covered Recipient Teaching Hospital
RONALD REAGAN UCLA
A Study of Ocular Toxicity Evaluation and Mitigation During Treatment With Mirvetuximab Soravtansine in Participants With Recurrent Ovarian Cancer With High Folate Receptor-Alpha Expression No dispute reported 06/30/2026 1202420431